NCT02327845 · ACTIVE NOT RECRUITING

Phenotype, Genotype & Biomarkers in ALS and Related Disorders

This is an observational study, so nothing is being tested as a treatment. Researchers are looking at how the genes and symptoms of ALS and related conditions, including frontotemporal dementia, connect. They also want to develop biomarkers, which are measurable body signals, to help future therapy research. No phase is listed.

Eligibility criteria

Inclusion Criteria:
* Member of at least one of the following categories:
  1. Individuals with a clinical diagnosis of ALS or a related disorder, including FTD, HSP, PLS, PMA and MSP (sporadic or familial).
  2. Family member of an enrolled affected individual.
* Able and willing to comply with relevant procedures.
Exclusion Criteria:
* Affected with end or late stage disease.
* A condition or situation which, in the PI's opinion, could confound the study finding or may interfere significantly with the individual's participation and compliance with the study protocol. This includes (but is not limited to) neurological, psychological and/or medical conditions.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-06-15

View full record on ClinicalTrials.gov

All APOE4 clinical trials